Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, Par Value $0.001 Per Share
-
Shares outstanding
-
47M
-
Number of holders
-
237
-
Total shares
-
51M
-
Shares change
-
-886K
-
Total reported value, excl. options
-
$768M
-
Value change
-
-$173M
-
Put/Call ratio
-
0.77
-
Number of buys
-
128
-
Number of sells
-
-152
-
Price
-
$15.05
Significant Holders of Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share (PCRX) as of Q3 2024
filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share as of Q3 2024.
Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share (PCRX) has 237 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51M shares
.
Largest 10 shareholders include BlackRock, Inc. (7.79M shares), VANGUARD GROUP INC (5.3M shares), Pacer Advisors, Inc. (4.96M shares), STATE STREET CORP (2.01M shares), RENAISSANCE TECHNOLOGIES LLC (1.98M shares), D. E. Shaw & Co., Inc. (1.96M shares), DIMENSIONAL FUND ADVISORS LP (1.87M shares), Doma Perpetual Capital Management LLC (1.75M shares), MORGAN STANLEY (1.6M shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (1.15M shares).
This table shows the top 237 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.